单辛酸甘油酯（C10）

Monocaprin is a new generation of high-tech products developed by using the company’s latest research results in functional lipids, and its active ingredients have the ability to inhibit the growth of various harmful bacteria, promote the development of intestinal mucosal cells,and regulate the intestinal icroecological balance. Adding monocaprin to feed can play an antiviral, antibacterial and antinflammatory role,improve animal production performance and meat quality.

Main features

• In vitro antiviral activity against enveloped viruses such as respiratory syncytial virus , sheep lentivirus and human immunodeficiency virus .
• Improves intestinal inflammation and oxidative stress and inhibits  the production of intestinal inflammatory cytokines , thereby improving intestinal barrier function
• In vitro bacteri cidal activity against Gram-positive and some Gram-negative bacteria .

Main effects

• Significant inhibition of Staphylococcus aureus , Escherichia coli , Salmonella , Campylobacter jejuni , Bacillus subtilis , Pseudomonas   aeruginosa and Candida albicans .
• Effectively increase the m RNA level of muscle fiber synthesis in
• farmed large yellow croaker , upregulate the metabolic pathway of protein and amino acid synthesis , and then improve the muscle texture and muscle fiber diameter of large yellow croaker . .
• Improve the intestinal morphology of pigs , reduce the level s of TNF- α and IL-6 in the serum , reduce intestinal inflammation , reduce morbidity and mortality rate , improve animal growth performance , and reduce the cost of comprehensive breeding.

Monocapri n Function Verification

In vitro antimicrobial test

According to the da ta in the above table , the inhibition circles of 2.5 mg/ml Monocapri n on Escherichia coli and Staphylococcus aureus could reach    27.20mm and 22.01mm , which were significantly higher than those of the  blank group , indicating that the inhibition effect of Monocapri n was good.

Monocapri n showed good inhibitory effect on E coli and Staphylococcus aureus with the minimal inhibitory concentrations of 0.16 and 0.08 , and   the minimal bacteri cidal concentrations of 2 .5 and 0 .63 mg/mL.

Feeding Instructions